Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer - Poll - MDSpire

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

  • By

  • Muhammad Talal Amin

  • Louis Coussement

  • Tim De Meyer

  • June 9, 2026

  • 0 min

Share

Original Source(s)

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

  • by Muhammad Talal Amin, Louis Coussement, Tim De Meyer

  • June 9, 2026

Related Content

Impact of clinical pharmacist-led medication management and education on tacrolimus therapeutic control

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement